Table 2 Clinical Characteristics of the Survive vs Dead Subjects

Age (years)^a

59.6 ± 13.4

64.29 ± 11.02

Gender^b

Man

Woman

17 (39.5%)

13(44.8%)

26 (60.5%)

16 (55.2%)

Episode stroke^b

New strokes

Recurrent strokes

20 (66.7%)

10 (33.3%)

31 (73.8%)

11 (26.2%)

Stroke Type^b

Ischemic stroke/SNH

Hemorrhagic stroke/SH

29 (6.7%)

1 (3.3%)

36 (85.7%)

6 (14.3%)

Systolic (mmHg)^a

144.2 ± 25.2

138.7 ± 30.9

Diastolic (mmHg)^a

88.6 ± 18.1

79.8 ± 16.8

Quantitative GCS^c (score)

15 (13–15)

12.5 (9–15)

Loss of consciousness^b

8 (26.7%)

25 (59.5%)

Motor deficit^b

25 (83.3%)

27 (64.3%)

Aphasia^b

7 (23.3%)

11 (26.2%)

Cranial nerve paresis^b

15 (50%)

22 (52.4%)

Focal seizures^b

1 (3.3%)

1 (2.4%)

Generalized seizures^b

5 (16.7%)

1 (2.4%)

NIHSS^c (score)

6 (2–10)

17 (11–23)

History of smoking^b

2 (6.7%)

6 (14.3%)

History of hypertension^b

20 (66.7%)

26 (61.9%)

History of DM^b

10 (33.3%)

22 (52.4%)

History of cardiac disease^b

6 (20%)

10 (23.8%)

History of dyslipidemia^b

9 (30%)

4 (9.5%)

History of renal Insufficiency^b

6 (20%)

13 (31%)

Severity of COVID-19^c

 Mild

 Moderate

 Severe

5 (16.7%)

17(56.7%)

8 (26.7%)

1 (2.4%)

11 (26.2%)

30 (71.4%)

Respiratory distress^b

1 (3.3%)

40 (95.2%)

Length of stay (LOS)^c

7.5 (6–9)

3 (3.5–11.5)